Evidence map›Paper›PMID 24733845›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2014

Maturation of innate responses to mycobacteria over the first nine months of life.

Muki S Shey, Elisa Nemes, Wendy Whatney, Marwou de Kock, Hadn Africa, Charlene Barnard, Michele van Rooyen, Lynnett Stone, Catherine Riou, Tobias Kollmann and 3 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide andJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Tuberculosis susceptibility and protection in children.The Lancet. Infectious diseases · 2019
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Factors influencing innate immunity and vaccine responses in infancy.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Muki S SheySouth African Tuberculosis Vaccine Initiative and School of Child and Adolescent Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa;
Elisa Nemes
Wendy Whatney
Marwou de Kock
Hadn Africa
Charlene Barnard
Michele van Rooyen
Lynnett Stone
Catherine Riou
Tobias Kollmann
Thomas R Hawn
Thomas J Scriba
Willem A Hanekom
South African Tuberculosis Vaccine Initiative · ZAUniversity of Cape Town · ZACentre for the AIDS Programme of Research in South Africa · ZAUniversity of British Columbia · CAUniversity of Washington · US

Funding

Host determinants of protection against tuberculosis in adolescentsR01AI087915 · NIAID · UNIVERSITY OF CAPE TOWN · PI SCRIBA, THOMAS JENS · 2011 to 2015
$3.3M
Innate Immunogenetics & Human InfectionsK24AI089794 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R · 2010 to 2014
$746k
NIAID NIH HHS K24 AI089794NIAID NIH HHS N01 AI070022NIAID NIH HHS R01 AI087915NIAID NIH HHS R01AI087915Wellcome Trust 084323
6 · The paper itself

Abstract

Newborns and young infants are particularly susceptible to infections, including Mycobacterium tuberculosis. Further, immunogenicity of vaccines against tuberculosis and other infectious diseases appears suboptimal early in life compared with later in life. We hypothesized that developmental changes in innate immunity would underlie these observations. To determine the evolution of innate responses to mycobacteria early in life, whole blood or PBMC from newborns, as well as 10- and 36-wk-old infants, was incubated with viable Mycobacterium bovis bacillus Calmette-Guérin or TLR ligands. Innate cell expression of cytokines and maturation markers was assessed, as well as activation of the proinflammatory NF-κB- and MAPK-signaling pathways. Bacillus Calmette-Guérin-induced production of the proinflammatory cytokines TNF-α, IL-6, and IL-12p40 increased from the newborn period to 9 mo of age in monocytes but not in myeloid dendritic cells. No changes in production of anti-inflammatory IL-10 were observed. CD40 expression increased with age in both cell populations. Older infants displayed substantial activation of all three signal transduction molecules: degradation of NF-κB inhibitor IκBα and phosphorylation of MAPK Erk and p38 upon TLR1/2 triggering, compared with predominant activation of only one of any of these molecules in newborns. Maturation of innate proinflammatory responses during the first 9 mo of life may underlie more effective control of mycobacteria and other pathogens observed later in infancy and age-related differential induction of Th1 responses by vaccination.

Indexed as

AdultAge FactorsAgingCD40 AntigensCytokinesFemaleHumansImmunity, InnateInfantInfant, NewbornMaleMAP Kinase Signaling SystemMonocytesMycobacterium bovisNF-kappa BToll-Like Receptor 1CD40 AntigensCytokinesNF-kappa BTLR2 protein, humanToll-Like Receptor 1Toll-Like Receptor 2

Identifiers

PMID24733845
PMCPMC4048703
OpenAlexW2133953064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.